NTRK1 and neoplasm: Accordingly, in vivo target inhibition (IVTI) confirmed the ability of Pz-1 to reduce phosphorylation of RET and TRKA, and some downstream signalling targets, at the doses used for tumour growth inhibition (Supplementary information, Figure S7).